Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisavanbulin in Advanced Solid Tumors and Recurrent Glioblastoma/High-Grade Glioma
NCT02490800Phase 2Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- May 2015
- Primary completion
- Sep 2022
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lisavanbulin in solid tumor (advanced stage), glioblastoma (GBM), glioma, sponsored by Basilea Pharmaceutica. Started May 2015; status: completed.
02
Drugs
lisavanbulin
03
Conditions
solid tumor (advanced stage)glioblastoma (GBM)glioma
Beyond the preview
Go deeper on NCT02490800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490800.